Inventor

SU HONGSHENG

CN8 patents

⚠️ This page may combine multiple inventors who share the name “SU HONGSHENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KIADIS PHARMA CANADA INC

2 patents

US8383672B2Feb 26, 2013

Halogenated rhodamine derivatives and applications thereof

KIADIS PHARMA CANADA INC10 citations80

US9636363B2May 2, 2017

Halogenated rhodamine derivatives and applications thereof

KIADIS PHARMA CANADA INC1 citations58

IBEX TECHNOLOGIES CORP

1 patent

US5919693AJul 6, 1999

Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum

IBEX TECHNOLOGIES CORP44 citations90

IBEX TECHNOLOGIES

1 patent

US5681733AOct 28, 1997

Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum

IBEX TECHNOLOGIES43 citations90

BIOMARIN PHARM INC

1 patent

US6841375B2Jan 11, 2005

Flavobacterium heparinum expression system

BIOMARIN PHARM INC15 citations78

CELMED BIOSCIENCES INC

1 patent

US7560574B2Jul 14, 2009

Halogenated rhodamine derivatives and applications thereof

CELMED BIOSCIENCES INC8 citations77

AMPSOURCE BIOPHARMA SHANGHAI INC

1 patent

US11471513B2Oct 18, 2022

Highly glycosylated human blood-clotting factor VIII fusion protein, and manufacturing method and application of same

AMPSOURCE BIOPHARMA SHANGHAI INC0 citations55

ZHENGZHOU GENSCIENCES INC

1 patent

US12440572B2Oct 14, 2025

FVIII fusion protein and use thereof

ZHENGZHOU GENSCIENCES INC0 citations39